HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
David Chardin Selected Research
David Chardin Research Topics
Disease
6
Neoplasms (Cancer)
01/2022 - 12/2019
2
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 01/2020
2
Breast Neoplasms (Breast Cancer)
01/2020 - 12/2019
1
Gastritis
01/2022
1
Parkinsonian Disorders (Parkinsonism)
01/2022
1
Inflammation (Inflammations)
01/2022
1
Lung Neoplasms (Lung Cancer)
12/2021
1
Carcinoma (Carcinomatosis)
10/2021
1
Ductal Carcinoma
12/2019
1
Body Weight (Weight, Body)
12/2019
1
Glioblastoma (Glioblastoma Multiforme)
01/2019
1
Brain Neoplasms (Brain Tumor)
01/2019
1
Residual Neoplasm
01/2019
1
Lipid Pneumonia
06/2017
1
Xeroderma Pigmentosum (Kaposi's Disease)
06/2017
Drug/Important Bio-Agent (IBA)
4
Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)
FDA Link
01/2022 - 06/2017
3
Biomarkers (Surrogate Marker)
IBA
01/2022 - 01/2020
2
Biological Products
IBA
01/2020 - 12/2019
1
Immune Checkpoint Inhibitors
IBA
01/2022
1
Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))
IBA
12/2021
1
Death Domain Receptors
IBA
01/2020
1
Blood Glucose (Blood Sugar)
IBA
12/2019
1
Estrogen Receptors
IBA
12/2019
1
Bevacizumab (Avastin)
FDA Link
01/2019
1
Lipids
IBA
06/2017
1
Pharmaceutical Preparations
IBA
06/2017
Therapy/Procedure
2
Immunotherapy
01/2022 - 01/2020
2
Therapeutics
01/2020 - 12/2019
2
Drug Therapy (Chemotherapy)
01/2020 - 01/2019
1
Denervation
01/2022
1
Neoadjuvant Therapy
12/2019
1
Aftercare (After-Treatment)
01/2019